The ability of poliovirus virion RNA and double-stranded RNA (replicative form) to replicate in enucleate mouse L cells was investigated. Virion RNA replicated successfully in the absence of the cell nucleus, whereas replicative form infection did not produce any detectable progeny in enucleate cells. The results provide direct evidence of a nuclear requirement early in the infection initiated by replicative form RNA. Several mechanisms have been proposed as the initial step of RF infection: (i) direct translation of the double-stranded molecule; (ii) denaturation of the molecule followed by translation of the plus strand; and (iii) transcription of the double-stranded template, yielding singlestranded RNA (4). Experiments with reconstructed heteroduplex RF molecules have led to the conclusion that only the plus strand is expressed (3, 8).
The question of the infectivity of picornavirus replicative form RNA (RF) (29, 36) , a by-product of infection, is intriguing. It is difficult to imagine how this molecule-a completely double-stranded RNA composed of a genome-like (plus) strand and a complementary (negative) strand-could initiate infection. It is generally agreed that the first step of infection by the single-stranded RNA of the virion is translation of the incoming RNA, yielding, among other products, RNA-dependent RNA polymerase (replicase) . The second step is replication of the parental RNA, accomplished by this newly synthesized enzyme and, possibly, other viral or cellular proteins (30) . The new RNA molecules produced may then become messengers, virion precursors, or templates for more RNA synthesis (for a review, see reference 41). How does picornavirus RF provide the messenger function after its entry into the host cell?
Several mechanisms have been proposed as the initial step of RF infection: (i) direct translation of the double-stranded molecule; (ii) denaturation of the molecule followed by translation of the plus strand; and (iii) transcription of the double-stranded template, yielding singlestranded RNA (4) . Experiments with reconstructed heteroduplex RF molecules have led to the conclusion that only the plus strand is expressed (3, 8) .
Infection of cells with purified single-stranded poliovirion RNA (PV-RNA) or with virions is resistant to treatment of the host cell with actinomycin D or a-amanitin. In contrast, the specific infectivity of RF is drastically reduced in the presence of these inhibitors (22, 34) . This observation has been interpreted to mean that a nuclear function may be involved in infection initiated by double-stranded RNA.
We have investigated the abilities of PV-RNA and poliovirus RF to replicate in enucleate cells. Here, we report that the host cell nucleus is required for RF infection, which, for the first time, provides direct evidence that one or several nuclear functions are involved in the conversion of double-stranded RNA to mRNA.
(This work was presented in part at the 77th Annual Meeting of the American Society for Microbiology, New Orleans, La., 1977).
MATERIALS AND METHODS
Cells and virus. The growth of HeLa cells in suspension culture in Eagle medium containing 5% calf serum and their infection by type 1 poliovirus (30 to 60 PFU per cell) in the presence of 5 ,ug of actinomycin D per ml has been described (13, 46) . A clonal derivative of strain L mouse cells was maintained in monolayer in minimal essential medium (Grand Island Biological Co., F-li) supplemented with 5% fetal calf serum (24) . This medium will be referred to as "normal medium" for L cells.
Preparation of virion RNA. Virus was isolated after 7 h of infection from a cytoplasmic extract prepared by Dounce homogenization (13) or freezing and thawing of the harvested cells in reticulocyte standard buffer (9) . After addition of EDTA to 2 mM and sodium dodecyl sulfate to 1%, the virus was pelleted and then purified by means of a sucrose gradient (9) . RNA was extracted from virus-containing fractions with phenol/chloroform (13) and subsequently sedimented through an 11-ml 15 to 30% sucrose gradient (9) at 24°C for 4.7 h at 40,000 rpm in an SW41 rotor (Beckman Instruments). Fractions containing 35S RNA were ethanol precipitated.
Preparation of polio RF. A cytoplasmic extract was prepared from poliovirus-infected HeLa cells 5 h after infection as follows (28) . The washed pellet of cells was suspended at 2 x 107 cells per ml in 0.035 M Tris-hydrochloride (pH 7.4)-0.14 M NaCl, and then a mixture of sodium deoxycholate and Triton X-100 (Sigma Chemnical Co.) was added dropwise to final VOL. 27, 1978 concentrations of 0.5 and 1%, respectively. After disruption of the cells with 10 strokes in a Dounce homogenizer, the nuclei and debris were removed by lowspeed centrifugation.
The supernatant was extracted twice with 0.5 volume of phenol/chloroform (13) . Total cytoplasmic nucleic acids present in the aqueous layer were precipitated three times with ethanol and fractionated with 2 M LiCl (13) . The nucleic acids contained in the supernatant were ethanol precipitated, treated with DNase, and separated on a Sepharose 2B column as described previously (47) .
Infectivity assays. Infectious poliovirus was titrated on HeLa cells by a modification of the plaque method of Cole et al. (9) . The base layers were formed by mixing equal amounts 2% agar Noble (Difco Laboratories) at 550C with twofold-concentrated medium containing 5% calf serum (55°C) and dispensing 8 to 10 ml into 60-mm petri dishes. Plates containing base layers were stored at 40C for no longer than 1 month. Samples were diluted serially in medium (or medium containing 1.5% calf serum [MCS] ), and 0.2 ml of the dilution was added to 0.6 ml of washed HeLa cells, resuspended at 107/ml in MCS in a test tube. The tube was warmed briefly in a 370C water bath; 0.6 ml 1.4% agar Noble in MCS (550C) was added, and the entire mixture was spread over the base layer. Plates were incubated at 370C in an atmosphere containing 5% C02 for 40 to 48 h. Four milliliters of 0.01% neutral red made up in wasmed medium was added to each plate; the stain was removed after 2 to 4 h at 370C, and plaques were made more visible by addition of 0.5 to 1.0 ml of glacial acetic acid to each plate.
A modification of the Bishop and Koch procedure (5,.19 ) was used to measure the infectivity of polio- (24) . Before enucleation or control treatments, all disks to be used in an experiment were centrifuged (11,000 x g, Sorvall SS-34 rotor, 370C) in normal medium for 10 min to remove loosely attached cells. This was done to insure nearly equivalent numbers of cells in all monolayers (1 x 105 to 2 x 105 per 1.3-cm disk).
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Two types of control nucleate cells were prepared for these experiments: (i) normal cells never treated with cytochalasin B and (ii) cells exposed to 10 ,ug of cytochalasin B per ml in a 370C incubator containing 5% C02 for the same time as enucleated monolayers. Neither type was centrifuged; hence, they were not enucleated. After enucleation or control treatments, the disks were placed in dishes of normal medium and incubated as above for 1 to 2 h before infection with RNA.
RNA infection of enucleate and nucleate monolayers. Disks carrying enucleate or nucleate monolayers were transferred to the chambers of a Linbro multidish Disposo-Tray (FB-16-24-TC) and washed by incubation at room temperature with warm Dulbecco phosphate-buffered saline for 15 min. After removal of the wash, the disks were inoculated with RNA (1 to 2 PFU per cell) in 20 to 25 A1 of phosphatebuffered saline containing 300 jg of DEAE-dextran per ml and placed in a 370C incubator (5% C02). The monolayers were then washed with warm phosphatebuffered saline, and 1.0 ml of normal medium at 370C was added. After incubation for 7 h longer, the infections were stopped by freezing at -200C. Subsequently, the infections were thawed, supernatant medium from each was combined with the corresponding infected cells that had been scraped into a wash of 0.5 ml of phosphate-buffered saline, and the mixture was subjected to three cycles of freezing and thawing to release intracellular virus. Virus production was titrated as described above. (11, 15, 35) . The 10-fold reduction in virus yield in PV-RNA-infected enucleates, as compared with nucleate control cells, is consistent with previous reports that the amount of virus production observed in poliovirus-infected enucleate cells is 10 to 40% of that of viruson November 6, 2017 by guest http://jvi.asm.org/ Downloaded from infected nucleate controls (15, 35) . This phenomenon has been attributed to loss of cytoplasm on enucleation (about 25%, by determination of stable RNA content [24, 25] Effect of recovery period after cytochalasin B treatment. Cytochalasin B, used to enucleate cells in these experiments, has been reported to enhance the infectivities of poliovirus (12) and isolated virion RNA (21) when cells are exposed to concentrations of drugs similar to those needed for enucleation a few minutes before or shortly after infection. The effect of cytochalasin B on RF infection is unknown. In view of these results and a report that cytochalasin B may transiently inhibit protein synthesis in uninfected cells (21), we considered that residual amounts of the drug might be responsible for the differential effect of enucleation, even though a recovery period was included in our procedure. To test whether enough drug remained to effect enhancement of virion RNA infection and to test whether this treatment affected RF infection in any way, the infectivities of RF and PV-RNA in untreated nucleate cells were compared to those in nucleate celLs treated with cytochalasin B for an amount of time equivalent to the exposure during enucleation (1.25 h). As in the enucleation procedure, drug treatment was followed by a 1.5-h incubation in normal medium; then, the cells were infected with RNA. The virus yields after 7 h of infection are shown in Table 3 .
RESULTS

Effect
Most of the cytochalasin B bound by cells during exposure is quickly lost (27) , and morphological effects of the drug are rapidly reversed (37) when drug-containing medium is replaced by normal medium. In line with these findings, no enhancement or inhibition of either RF or PV-RNA infectivity occurred when cytochalasin treatment of enucleate cells was followed by a period in drug-free medium (Table   3) . Monolayers of L cells were prepared and centrifuged to remove loosely attached cells as described in the text. One group of disks was then incubated in medium containing 10 jg of CB per ml for 1.25 h. 
DISCUSSION
The development of methods for large-scale enucleation of cells in culture has made it possible to investigate the relationship of nucleus and cytoplasm in various biological processes (for a review, see reference 37). The technique was quickly applied to the question of nuclear participation in a number of virus infections (10, 15-18, 23, 32, 35, 38, 44, 45) , and, in the case of polio and several other viruses, the results often confirmed and extended conclusions from inhibitor studies, autoradiography, and/or cell fractionation.
The major events of infection initiated by virus particles or virion RNA (in the presence of various adjuvants [20] ) are thought to be nearly identical, because the two processes are similarly affected by treatments with actinomycin D (22) or cytochalasin B (12, 21) and because there are no polymerases associated with the virion (2). Thus, the 35S RNA resulting from in vitro deproteinization of virions should be identical to the virus component remaining after uncoating of the virion inside the cell, and the same events for initiation of replication should ensue. Our finding that virion RNA can replicate successfully in enucleate cells corroborates this idea, inasmuch as the cycle initiated by virions is also completely independent of the nucleus (11, 15, 26, 35) .
Virus infection is resistant to actinomycin D and a-amanitin (34, 41) , and, as noted above, virion RNA infection is also unaffected by actinomycin D. In contrast, available evidence suggests that infection initiated by RF is sensitive to all these inhibitors. In the case of actinomycin D, at least, the infection becomes refractory after 1 h (34) . The data implicate a nuclear function early in the RF-initiated replication cycle (33) . However, this interpretation rests upon the assumption that the site of action of the drugs is the nucleus only. This may not be so.
To obtain direct evidence of a role that the host cell nucleus may play in RF infection, we have used cells that were physically enucleated. The absence of detectable virus progeny in RFinfected enucleate cells clearly shows that the nucleus is involved in RF infection, presumably in the early stages.
Since single-stranded virion RNA infection is independent of the nucleus, once such a molecule is generated in the RF-infected cell, the nuclear requirement should be eliminated. It is, therefore, most likely that the nuclear role is that of mediator of the process which yields genome polarity single-stranded RNA. In addition, the mechanism should discriminate against expression of the negative strand of RF, which adds an intriguing specificity to the early events in RF infection (3, 8) . To accomplish this, the data suggest that RF infection takes advantage of an unstable cytoplasmic host factor, of a stable host factor which is confined to the nucleus, or of an induced host factor. The 
